Drug
XH S003
XH S003: highest development phase Phase 2, developed by Shanghai Fosun Pharmaceutical. 4 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shanghai Fosun Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| XH-S003 Capsule NCT07634744 | Phase 2 | IgA Nephropathy |
| XH-S003 (A) NCT05946876 | Phase 1 | |
| XH-S003 NCT06272747 | Phase 1 | Healthy Adults |
| XH-S003 Capsule NCT07657052 | Not Applicable | Paroxysmal Nocturnal Hemoglobinuria |
Latest
No recent events.
Follow XH S003 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.